Schepens B - Search Results

1

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L; VIB-CMB COVID-19 Response Team; Hoffmann M, Pöhlmann S, Graham BS, Callewaert N, Schepens B, Saelens X, McLellan JS. Wrapp D, et al. Among authors: schepens b. Cell. 2020 Jun 11;181(6):1436-1441. doi: 10.1016/j.cell.2020.05.047. Cell. 2020. PMID: 32531248 Free PMC article. No abstract available.

2

Hepatitis B core-based virus-like particles to present heterologous epitopes.

Roose K, De Baets S, Schepens B, Saelens X. Roose K, et al. Among authors: schepens b. Expert Rev Vaccines. 2013 Feb;12(2):183-98. doi: 10.1586/erv.12.150. Expert Rev Vaccines. 2013. PMID: 23414409 Review.

3

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.

Cardoso FM, Ibañez LI, Van den Hoecke S, De Baets S, Smet A, Roose K, Schepens B, Descamps FJ, Fiers W, Muyldermans S, Depicker A, Saelens X. Cardoso FM, et al. Among authors: schepens b. J Virol. 2014 Aug;88(15):8278-96. doi: 10.1128/JVI.03178-13. Epub 2014 May 14. J Virol. 2014. PMID: 24829341 Free PMC article.

4

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.

Schepens B, Schotsaert M, Saelens X. Schepens B, et al. Immunotherapy. 2015;7(3):203-6. doi: 10.2217/imt.15.11. Immunotherapy. 2015. PMID: 25804473 Free article. No abstract available.

5

IgG3 Snitcher of RSV Infections in the Very Young.

Schepens B, Saelens X. Schepens B, et al. EBioMedicine. 2017 Feb;16:10-11. doi: 10.1016/j.ebiom.2017.01.039. Epub 2017 Jan 30. EBioMedicine. 2017. PMID: 28159571 Free PMC article. No abstract available.

6

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.

Rossey I, Gilman MS, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Rossey I, et al. Among authors: schepens b. Nat Commun. 2017 Feb 13;8:14158. doi: 10.1038/ncomms14158. Nat Commun. 2017. PMID: 28194013 Free PMC article.

7

Clinical Potential of Prefusion RSV F-specific Antibodies.

Rossey I, McLellan JS, Saelens X, Schepens B. Rossey I, et al. Among authors: schepens b. Trends Microbiol. 2018 Mar;26(3):209-219. doi: 10.1016/j.tim.2017.09.009. Epub 2017 Oct 17. Trends Microbiol. 2018. PMID: 29054341 Review.

8

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.

Rossey I, Gilman MSA, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Rossey I, et al. Among authors: schepens b. Nat Commun. 2017 Nov 29;8:16165. doi: 10.1038/ncomms16165. Nat Commun. 2017. PMID: 29184149 Free PMC article.

9

Vaccine options for influenza: thinking small.

Schepens B, De Vlieger D, Saelens X. Schepens B, et al. Curr Opin Immunol. 2018 Aug;53:22-29. doi: 10.1016/j.coi.2018.03.024. Epub 2018 Apr 7. Curr Opin Immunol. 2018. PMID: 29631195 Review.

10

Single-Domain Antibodies and Their Formatting to Combat Viral Infections.

De Vlieger D, Ballegeer M, Rossey I, Schepens B, Saelens X. De Vlieger D, et al. Among authors: schepens b. Antibodies (Basel). 2018 Dec 20;8(1):1. doi: 10.3390/antib8010001. Antibodies (Basel). 2018. PMID: 31544807 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page